|
|
| Nomenclature |
|
Symbol:
|
Tg(CD19-cre/ERT2)1Cgn
|
|
Name:
|
transgene insertion 1, University of Cologne
|
|
MGI ID: |
MGI:3037896 |
|
Synonyms: |
CD19-Cre, hCD19-CreERT2 |
|
Transgene:
|
Tg(CD19-cre/ERT2)1Cgn
Location:
unknown
|
|
Transgene
origin |
|
Strain of Origin:
|
Not Specified
|
|
Transgene
description |
|
Transgene
Type: | |
Transgenic (Cre/Flp) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: This transgene expresses a tamoxifen inducible form of cre recombinase from the human B cell specific CD19 promoter.
|
|
|
Recombinase activity
|
|
Driver:
|
CD19
Summary of all recombinase alleles
driven by CD19.
|
|
MGI has not yet included tissue activity data for this allele in any anatomical systems.
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available |
|
| References |
|
Original: |
J:88472
Casola S et al.,
"B cell receptor signal strength determines B cell fate."
Nat Immunol 2004 Mar;5(3):317-27
|
|
All: |
11 reference(s)
|
|
Analysis Tools
